O’Bell

HIF Away: Roxadustat Has Arrived!

August 2, 2016 // 0 Comments

Anemia management in patients with end-stage renal disease (ESRD) has always been a complicated process.  Prior to the introduction of recombinant human erythropoietin, the vast majority of patients receiving dialysis were transfusion dependent.  [read more...]